• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白蛋白-中性粒细胞与淋巴细胞比值(Albumin-dNLR)评分可作为判定70岁以上内科住院患者中GLIM炎症负担的病因学标准:一项多中心回顾性研究。

Albumin-dNLR score could be an etiological criterion to determine inflammation burden for GLIM in medical inpatients over 70 years old: A multicenter retrospective study.

作者信息

Xu Jingyong, Hu Yifu, Wang Lijuan, Li Pengxue, Zhu Mingwei, Song Jinghai, Wei Junmin

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, China.

Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Heliyon. 2024 Jul 4;10(13):e34102. doi: 10.1016/j.heliyon.2024.e34102. eCollection 2024 Jul 15.

DOI:10.1016/j.heliyon.2024.e34102
PMID:39091958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11292551/
Abstract

AIM

To validate the role of the albumin-derived neutrophil-to-lymphocyte (ALB-dNLR) score in diagnosing malnutrition in medical inpatients over 70 years old.

METHODS

This is a retrospective cross-sectional study involving 7 departments from 14 Chinese hospitals. The ALB-dNLR score was calculated, and outcomes between groups with positive and negative ALB-dNLR scores were compared after propensity score matching (PSM). Afterwards, the outcomes were compared between the groups receiving nutrition support and those not receiving support among malnourished patients diagnosed using the Global Leadership Initiative Malnutrition (GLIM) criteria after PSM.

RESULTS

Out of 10,184 cases, 6165 were eligible. 2200 cases were in the positive ALB-dNLR score group. After PSM, 1458 pairs were analyzed, showing lower in-hospital mortality (0.8 % vs. 2.1 %, p = 0.005) and a lower nosocomial infection rate (5.9 % vs. 11.0 %, p < 0.001) in the negative ALB-dNLR score group. In malnourished patients, 259 pairs were analyzed after PSM. It showed better outcomes in mortality (0.8 % vs. 3.5 %, p = 0.033), nosocomial infection rate (5.4 % vs. 15.4 %, p < 0.001), length of stay (LOS) (13.8 ± 10.3 vs. 18.4 ± 14.1, p < 0.001), and total hospital cost (3315.3 ± 2946.4 vs. 4795.3 ± 4198.2, p < 0.001) in the support group. In malnourished patients with ALB-dNLR score as the sole etiological criterion, 94 pairs were calculated. It showed better outcomes in mortality (0.0 % vs. 6.4 %, p = 0.029), nosocomial infection rate (7.4 % vs. 18.1 %, p = 0.029), LOS (13.7 ± 8.3 vs. 19.8 ± 15.2, p = 0.001), and total hospital cost (3379.3 ± 2955.6 vs. 4471.2 ± 4782.4, p = 0.029) in the support group.

CONCLUSIONS

The ALB-dNLR score was validated to predict in-hospital mortality in medical inpatients over 70 years old. Malnutrition patients diagnosed by the GLIM criteria and using the ALB-dNLR score might benefit from nutrition support.

摘要

目的

验证白蛋白衍生的中性粒细胞与淋巴细胞比值(ALB-dNLR)评分在诊断70岁以上内科住院患者营养不良中的作用。

方法

这是一项回顾性横断面研究,涉及中国14家医院的7个科室。计算ALB-dNLR评分,并在倾向得分匹配(PSM)后比较ALB-dNLR评分阳性和阴性组的结局。之后,在PSM后,比较使用全球营养不良领导倡议(GLIM)标准诊断的营养不良患者中接受营养支持和未接受营养支持的组之间的结局。

结果

在10184例病例中,6165例符合条件。2200例在ALB-dNLR评分阳性组。PSM后,分析了1458对,结果显示ALB-dNLR评分阴性组的住院死亡率较低(0.8%对2.1%,p = 0.005),医院感染率较低(5.9%对11.0%,p < 0.001)。在营养不良患者中,PSM后分析了259对。结果显示,支持组在死亡率(0.8%对3.5%,p = 0.033)、医院感染率(5.4%对15.4%,p < 0.001)、住院时间(LOS)(13.8±10.3对18.4±14.1,p < 0.001)和总住院费用(3315.3±2946.4对4795.3±4198.2,p < 0.001)方面有更好的结局。在以ALB-dNLR评分为唯一病因标准的营养不良患者中,计算了94对。结果显示,支持组在死亡率(0.0%对6.4%,p = 0.029)、医院感染率(7.4%对18.1%,p = 0.029)、LOS(13.7±8.3对19.8±15.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/a522fc6ff585/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/400eb500ee30/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/88dfadebf55f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/216a25773879/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/a522fc6ff585/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/400eb500ee30/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/88dfadebf55f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/216a25773879/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010f/11292551/a522fc6ff585/gr4.jpg

相似文献

1
Albumin-dNLR score could be an etiological criterion to determine inflammation burden for GLIM in medical inpatients over 70 years old: A multicenter retrospective study.白蛋白-中性粒细胞与淋巴细胞比值(Albumin-dNLR)评分可作为判定70岁以上内科住院患者中GLIM炎症负担的病因学标准:一项多中心回顾性研究。
Heliyon. 2024 Jul 4;10(13):e34102. doi: 10.1016/j.heliyon.2024.e34102. eCollection 2024 Jul 15.
2
ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention.白蛋白-中性粒细胞与淋巴细胞比值(ALB-dNLR)评分可预测冠心病患者经皮冠状动脉介入治疗后的死亡率。
Front Cardiovasc Med. 2022 Mar 15;9:709868. doi: 10.3389/fcvm.2022.709868. eCollection 2022.
3
Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria.改善癌症患者营养不良评估:将系统性炎症标志物作为 GLIM 标准炎症指标的补充。
Clin Nutr. 2023 Oct;42(10):2036-2044. doi: 10.1016/j.clnu.2023.08.020. Epub 2023 Sep 1.
4
Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.白蛋白-中性粒细胞与淋巴细胞比值评分作为新的预测指标用于接受新辅助放化疗的局部进展期直肠癌患者。
Anticancer Res. 2024 Jan;44(1):229-237. doi: 10.21873/anticanres.16806.
5
Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.白蛋白衍生中性粒细胞与淋巴细胞比值评分作为胃癌纳武利尤单抗治疗敏感性标志物的多中心研究。
In Vivo. 2023 Mar-Apr;37(2):818-824. doi: 10.21873/invivo.13147.
6
Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.白蛋白衍生的 NLR 评分是食管鳞癌的一种新的预后标志物。
Ann Surg Oncol. 2022 Apr;29(4):2663-2671. doi: 10.1245/s10434-021-11012-y. Epub 2021 Nov 22.
7
A Cross-Sectional Study of GLIM-Defined Malnutrition Based on New Validated Calf Circumference Cut-off Values and Different Screening Tools in Hospitalised Patients over 70 Years Old.基于新的经过验证的小牛颈围截断值和不同筛查工具的 GLIM 定义的营养不良的横断面研究:超过 70 岁的住院患者。
J Nutr Health Aging. 2020;24(8):832-838. doi: 10.1007/s12603-020-1386-4.
8
The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis.类风湿关节炎患者血清白蛋白与中性粒细胞与淋巴细胞比值(dNLR)评分与疾病活动度的相关性
J Clin Lab Anal. 2019 Mar;33(3):e22695. doi: 10.1002/jcla.22695. Epub 2018 Oct 15.
9
Machine Learning-Based Prediction of Complications and Prolonged Hospitalization with the GLIM Criteria Combinations Containing Calf Circumference in Elderly Asian Patients.基于机器学习的基于 GLIM 标准组合(包含小腿围)的老年亚洲患者并发症和住院时间延长的预测。
Nutrients. 2023 Sep 26;15(19):4146. doi: 10.3390/nu15194146.
10
GLIM Criteria Using Hand Grip Strength Adequately Predict Six-Month Mortality in Cancer Inpatients.GLIM 标准使用握力可充分预测癌症住院患者的六个月死亡率。
Nutrients. 2019 Sep 1;11(9):2043. doi: 10.3390/nu11092043.

本文引用的文献

1
Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.白蛋白-中性粒细胞与淋巴细胞比值评分作为新的预测指标用于接受新辅助放化疗的局部进展期直肠癌患者。
Anticancer Res. 2024 Jan;44(1):229-237. doi: 10.21873/anticanres.16806.
2
Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.白蛋白衍生中性粒细胞与淋巴细胞比值评分作为胃癌纳武利尤单抗治疗敏感性标志物的多中心研究。
In Vivo. 2023 Mar-Apr;37(2):818-824. doi: 10.21873/invivo.13147.
3
Malnutrition risk screening: New insights in a new era.
营养不良风险筛查:新时代的新视角。
Clin Nutr. 2022 Oct;41(10):2163-2168. doi: 10.1016/j.clnu.2022.08.007. Epub 2022 Aug 17.
4
Prospective validation of five malnutrition screening and assessment instruments among medical inpatients: Secondary analysis of a randomized clinical trial.前瞻性验证五种营养不良筛选和评估工具在住院患者中的应用:一项随机临床试验的二次分析。
Clin Nutr. 2022 Jun;41(6):1307-1315. doi: 10.1016/j.clnu.2022.04.025. Epub 2022 Apr 26.
5
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition.用于评估全球营养不足倡议(GLIM)营养不良诊断中肌肉量表型标准的指导意见。
Clin Nutr. 2022 Jun;41(6):1425-1433. doi: 10.1016/j.clnu.2022.02.001. Epub 2022 Apr 19.
6
Validation of modified GLIM criteria to predict adverse clinical outcome and response to nutritional treatment: A secondary analysis of a randomized clinical trial.改良GLIM标准预测不良临床结局及营养治疗反应的验证:一项随机临床试验的二次分析
Clin Nutr. 2022 Apr;41(4):795-804. doi: 10.1016/j.clnu.2022.02.009. Epub 2022 Feb 17.
7
Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial.营养不良风险住院患者的入院血清白蛋白浓度及对营养治疗的反应:一项随机临床试验的二次分析
EClinicalMedicine. 2022 Feb 11;45:101301. doi: 10.1016/j.eclinm.2022.101301. eCollection 2022 Mar.
8
Utilization and validation of the Global Leadership Initiative on Malnutrition (GLIM): A scoping review.利用和验证全球营养不良领导倡议 (GLIM):范围综述。
Clin Nutr. 2022 Mar;41(3):687-697. doi: 10.1016/j.clnu.2022.01.018. Epub 2022 Feb 1.
9
Malnutrition, Sarcopenia, and Malnutrition-Sarcopenia Syndrome in Older Adults with COPD.老年人慢性阻塞性肺疾病患者的营养不良、肌肉减少症和营养不良-肌肉减少症综合征。
Nutrients. 2021 Dec 23;14(1):44. doi: 10.3390/nu14010044.
10
Different combinations of the GLIM criteria for patients awaiting a liver transplant: Poor performance for malnutrition diagnosis but a potentially useful prognostic tool.不同的 GLIM 标准组合用于等待肝移植的患者:营养不良诊断的表现不佳,但可能是一种有用的预后工具。
Clin Nutr. 2022 Jan;41(1):97-104. doi: 10.1016/j.clnu.2021.11.008. Epub 2021 Nov 14.